Categories
Most Viewed Transcripts
- Netflix Inc (NFLX) Q3 2023 Earnings Call Transcript
- Tesla Inc (TSLA) Q3 2023 Earnings Call Transcript
- Accenture plc (ACN) Q3 2023 Earnings Call Transcript
- Steelcase Inc. (SCS) Q1 2024 Earnings Call Transcript
- Avid Bioservices Inc. (CDMO) Q4 2023 Earnings Call Transcript
- Patterson Companies, Inc. (PDCO) Q4 2023 Earnings Call Transcript
Latest News
Analysis
Earnings Preview: Walmart (WMT) expected to report sales and profit gains in Q1
Over the years, Walmart Inc. (NYSE: WMT) has constantly diversified while maintaining its dominance in the retail world. The company is preparing
What to look for when Take-Two Interactive Software (TTWO) reports Q4 2024 earnings results
Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) stayed red on Thursday. The stock has dropped 14% over the past three months.
After a positive year, what’s in the cards for Electronic Arts (EA) in FY25
Electronic Arts (NASDAQ: EA) ended fiscal 2024 on a mixed note, reporting lower revenues and improved bottom-line performance for the fourth quarter.
Interviews
AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.
Most Read
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a growing network of suppliers and partnerships with independent
May 10, 2024
Earnings Preview: Walmart (WMT) expected to report sales and profit gains in Q1
Over the years, Walmart Inc. (NYSE: WMT) has constantly diversified while maintaining its dominance in the retail world. The company is preparing to report financial results for the first three
May 9, 2024
After a positive year, what’s in the cards for Electronic Arts (EA) in FY25
Electronic Arts (NASDAQ: EA) ended fiscal 2024 on a mixed note, reporting lower revenues and improved bottom-line performance for the fourth quarter. The stock declined following the announcement as earnings
May 8, 2024
Technology
Energy
Consumer
Industrials
Health Care
Research Summary
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes
Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that works with leading researchers